Cisplatin cytopenia

Author: pfmh

August undefined, 2024

WebSep 18, 2024 · NCBI Bookshelf WebMay 6, 2009 · The regimen is designed for patients intended to proceed to autografting and the long-term efficacy and toxicity of giving a higher number of cycles without autograft, an approach reported with other gemcitabine/cisplatin combination regimens has …

Thrombocytopenia: Managing Low Platelets During Chemotherapy

WebJun 1, 2009 · We report a gemcitabine, cisplatin, and dexamethasone regimen (GemCis) with intensive growth factor and platelet support and no treatment delay. Seventeen patients with relapsed or refractory... WebCisplatin is an intravenous (I.V.) infusion that is typically given over one to two hours; Cumulative toxicity to kidneys from cisplatin can be severe ; Other toxicities from … mondo and rockna

Paclitaxel, Ifosfamide and Cisplatin Regimen is Feasible for

WebCisplatin is contraindicated according to two German summary of product characteristics (SmPC) in patients with a creatinine clearance < 60 mL/min. … WebFeb 16, 2024 · Cisplatin Dosage Medically reviewed by Drugs.com. Last updated on Feb 16, 2024. Applies to the following strengths: 50 mg; 10 mg; 1 mg/mL Usual Adult Dose … WebAug 1, 2024 · Subgroup analyses revealed that the benefit of cisplatin persisted in women aged ≥75 years and those with early-stage disease. Incidence of cytopenia, nausea/vomiting, and hypovolemia increased in patients treated with cisplatin. mondo accounting chicago

NCBI Bookshelf

Web开馆时间：周一至周日7:00-22:30 周五 7:00-12:00; 我的图书馆 WebMay 6, 2009 · @article{Todd2009IntermediateDG, title={Intermediate dose gemcitabine–cisplatin combination chemotherapy without treatment delay for cytopenia followed by autografting—a new standard of care in relapsed or refractory Hodgkin lymphoma?}, author={Tony Todd and Sonia Raj and David James Camilleri and … icacls azure file shareElectrolyte disturbance: Cisplatin can cause hypomagnesaemia, hypokalaemia and hypocalcaemia. The hypocalcaemia seems to occur in those with low serum magnesium secondary to cisplatin, so it is not primarily due to the cisplatin. Hemolytic anemia can be developed after several courses of cisplatin. See more Cisplatin is a chemotherapy medication used to treat a number of cancers. These include testicular cancer, ovarian cancer, cervical cancer, bladder cancer, head and neck cancer, esophageal cancer, lung cancer See more Cisplatin interferes with DNA replication, which kills the fastest proliferating cells, which in theory are cancerous. Following administration, one chloride ion is slowly displaced by water … See more The compound cis-[Pt(NH3)2Cl2] was first described by Italian chemist Michele Peyrone in 1845, and known for a long time as Peyrone's salt. The structure was deduced by See more Cisplatin is administered intravenously as short-term infusion in normal saline for treatment of solid and haematological malignancies. It is used to treat various types of cancers, … See more Cisplatin has a number of side effects that can limit its use: • Nephrotoxicity (kidney damage) is the primary dose-limiting side effect and is of major clinical concern. Cisplatin selectively accumulates into the proximal tubule via basolateral-to … See more Cisplatin is the square planar coordination complex cis-[Pt(NH3)2Cl2]. The prefix cis indicates the cis isomer in which two similar ligands are in … See more Syntheses of cisplatin start from potassium tetrachloroplatinate. Several procedures are available. One obstacle is the facile formation of Magnus's green salt (MGS), which has the same empirical formula as cisplatin. The traditional way to avoid MGS involves the … See more ica coaching academy

"WebTherapy consisted of cisplatin, 100 mg/m2 on day 1, and vinorelbine, 25 mg/m2 on days 1 and 8, given every 21 days. Therapy was continued up to six courses or progressive disease.Results.One hundred fifty-nine courses were given (median, three per patient). Dose reduction was applied in 13% of courses and 43% of patients. " - Cisplatin cytopenia

Thrombocytopenia: Managing Low Platelets During Chemotherapy

Paclitaxel, Ifosfamide and Cisplatin Regimen is Feasible for

Cisplatin cytopenia

Did you know?